| Identification | Back Directory | [Name]
Ozagrel methylester | [CAS]
866157-50-8 | [Synonyms]
Ozagrel impurity G
Ozagrel methylester
Methyl 3-(4-(1H-imidazol-1-yl)phenyl)acrylate
(E)-methyl 3-(4-(1H-imidazol-1-yl)phenyl)acrylate
methyl 3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate
Methyl (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylate
(E)-methyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate
3-[4-(1H-Imidazol-1-yl)phenyl]-2-propenoic acid methyl ester
-Propenoicacid, 3-[4-(1H-iMidazol-1-yl)phenyl]-, Methyl ester
Methyl (2E)-3-[4-(1H-iMidazol-1-ylMethyl)phenyl]prop-2-enoate
2-Propenoic acid, 3-[4-(1H-imidazol-1-yl)phenyl]-, methyl ester
methyl (2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]prop-2-enoat...
Ozagrel methyl ester
3-[4-(1H-Imidazol-1-yl)phenyl]-2-propenoic acid methyl ester | [Molecular Formula]
C13H12N2O2 | [MDL Number]
MFCD11035750 | [MOL File]
866157-50-8.mol | [Molecular Weight]
228.25 |
| Hazard Information | Back Directory | [Uses]
Ozagrel is a potent and selective thromboxane A2 inhibitor. Used in the prevention of ischemic stroke injury and maintains a strong effect in vascular contraction and vascular endothelial cell dysfunction. |
|
|